Healthpeak Properties Faces Challenges Amid Rising Interest Rates
By John Nada·Mar 22, 2026·6 min read
Healthpeak Properties is facing a significant stock decline due to rising interest rates and challenges in leasing activity. This underperformance highlights broader issues within the REIT sector.
Healthpeak Properties, Inc. (DOC) is struggling with significant stock declines, down 16.9% from its 52-week high as rising interest rates impact real estate investment trusts (REITs). This decline reflects a broader trend affecting income-focused assets, driven by increased borrowing costs and reduced investor appetite.
The company's transition towards life sciences properties introduces additional leasing and reinvestment risks, compounding its challenges. Healthpeak Properties focuses on owning, operating, and developing high-quality healthcare-related properties across the United States, which includes life sciences campuses, outpatient medical offices, and senior housing facilities. This diversified real estate portfolio plays a crucial role in supporting healthcare delivery and innovation. However, the shift towards these life sciences properties has not been without its difficulties.
Despite a modest 6.6% gain over the past three months, Healthpeak still lags behind the Real Estate Select Sector SPDR Fund (XLRE), which saw only a marginal rise during this period. Investors may be cautious as they weigh the potential benefits of Healthpeak's focus on life sciences against the current economic headwinds.
Over the past six months, Healthpeak's stock has slumped 7.7%, underperforming XLRE's 3% decline. This underperformance is notable, especially when compared to peers such as Omega Healthcare Investors, Inc. (OHI), which has gained 7.9% over the same period. The contrasting performance raises questions about Healthpeak's long-term growth strategy amid a shifting economic landscape.
Compounding this issue is slower leasing activity in key lab campuses, which has been a significant area of focus for the company as part of its strategy to enhance its portfolio. This slowdown is not just a fleeting concern; it represents broader weaknesses in the real estate sector that could have lasting implications. Additionally, financial pressures among biotech tenants are exacerbating the situation, dampening growth expectations and raising doubts about future revenue streams.
Healthpeak Properties has a market cap of around $11.9 billion, categorizing it as a large-cap stock. This classification typically suggests stability and a degree of resilience in the face of market fluctuations. However, the current climate indicates that even large-cap stocks are not immune to the pressures of rising interest rates. Companies with market caps of $10 billion or more are often more closely scrutinized by investors, and Healthpeak's challenges are drawing attention.
The REIT is currently down by 16.9% from its 52-week high of $20.52 touched in March 2025. This decline signifies a significant drop in investor confidence, which is crucial for a company operating in a sector that relies heavily on steady income streams. Rising interest rates have weighed heavily on REIT valuations, increasing borrowing costs and reducing investor appetite for income-focused assets. The higher costs of borrowing could hinder Healthpeak's ability to finance new projects or invest in reinvestment opportunities, leading to a potential stagnation in growth.
While Healthpeak has experienced a modest uptick of 6.6% over the past three months, this improvement is perhaps not enough to offset the broader downward trajectory of its stock. The company has outperformed the Real Estate Select Sector SPDR Fund’s (XLRE) small rise during this time frame, but it still reflects lingering challenges within the sector.
Examining the stock's performance over the previous 52 weeks reveals that DOC plunged 16.2%, underperforming XLRE’s 3.2% decrease. This broader market trend is concerning, especially considering that Healthpeak's focus on healthcare-related properties was once seen as a stabilizing factor amid economic uncertainty.
Healthpeak Properties has emphasized disciplined execution and a focused approach, which are essential strategies for navigating the current tumultuous market. The company's ability to adapt to changing conditions will be vital. Investors are looking for indicators that Healthpeak can successfully manage its transition towards life sciences properties while mitigating risks associated with leasing and reinvestment.
Despite the challenges posed by rising interest rates and the sluggish leasing activity in key lab campuses, Healthpeak's diversified portfolio could provide some level of insulation against market volatility. The emphasis on healthcare-related assets may offer a degree of protection, as these properties typically serve essential needs. However, the financial pressures facing biotech tenants underscore the complexities of the current environment.
The current dynamics in the labor market are also contributing to the challenges faced by Healthpeak Properties. Slower leasing activity is a reflection of broader economic trends, including supply chain disruptions and labor shortages that have affected various sectors. These issues can lead to delays in leasing agreements and ultimately impact the revenue streams for Healthpeak.
As Healthpeak navigates these issues, the company must also consider how it positions itself relative to competitors. Omega Healthcare Investors, Inc. has shown resilience with a 19.1% surge over the past year, highlighting a stark contrast to Healthpeak's struggles. This performance comparison raises questions about Healthpeak's strategic decisions and whether they align with market demands and investor expectations.
The REIT sector often requires companies to be agile and responsive to both market conditions and investor sentiment. Healthpeak's current performance suggests that it may need to reassess its strategies to ensure it remains competitive. The healthcare real estate market is evolving, and companies that can adapt quickly and effectively are likely to fare better in the long term.
Additionally, the trends in healthcare and life sciences are constantly changing, and Healthpeak's management will need to stay ahead of these shifts. As more investors seek opportunities in life sciences real estate, Healthpeak could benefit if it can effectively capitalize on market demands while managing the inherent risks associated with this transition.
The pressures exerted by rising interest rates should not be underestimated, as they have a profound effect on investor behavior and market valuations. Healthpeak's ability to manage its debt levels and maintain a strong balance sheet will be crucial in weathering this storm. Financial prudence will be key to navigating the challenges posed by both the macroeconomic environment and sector-specific issues.
In terms of operational strategy, Healthpeak Properties must engage in proactive communication with its stakeholders, including investors, tenants, and partners. Transparency regarding leasing activities, tenant financial health, and strategic initiatives will be essential in maintaining investor confidence. The willingness to adapt and evolve in response to the changing landscape can help Healthpeak build a more resilient business model.
Investors are particularly attuned to the performance metrics of REITs, and Healthpeak's ability to deliver consistent returns will ultimately dictate its success. The focus on high-quality healthcare real estate remains a promising avenue, but the execution of that vision amid rising interest rates and slower market conditions will be the determining factor.
As we look ahead, it’s clear that Healthpeak Properties is at a crossroads. The decisions made in response to current challenges will shape the company’s trajectory in the coming years. Stakeholders will be watching closely to see how Healthpeak adapts to the pressures of rising interest rates, manages its transition to life sciences properties, and addresses the financial pressures faced by its tenants. The outcome of these efforts will be critical in defining Healthpeak's future performance in the real estate investment trust arena.